Bone Grafts And Substitutes Market (2026 - 2033) Size, Share & Trends Analysis Report By Material Type (Allograft, Synthetic), By Application (Spinal Fusion, Dental, Joint Reconstruction), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts

Bone Grafts And Substitutes Market Summary

The global bone grafts and substitutes market size was estimated at USD 3.34 billion in 2025 and is projected to reach USD 5.50 billion by 2033, growing at a CAGR of 5.6% from 2026 to 2033. Increasing utilization of bone grafts and substitutes in various applications such as spinal fusion, orthopedic fracture healing, periodontal defect repair, dental alveolar ridge augmentation, and wound care with skin equivalents primarily drives the growth of this market.

Significant technological advancements, the emergence of synthetic bone grafts, the availability of novel surgical solutions, and substantial changes in regenerative medicine are expected to develop lucrative growth opportunities for the bone grafts and substitutes market.

Increasing demand for synthetic bone grafts, primarily driven by factors such as risks of infection and limited supply, has stimulated new product developments and growing efforts focused on R&D associated with bone grafts. Moreover, the launch of innovation-based solutions by prominent manufacturers indicates the growth potential of this market. For instance, in December 2025, Xtant Medical Holdings, Inc., a surgical solutions provider for spinal and other orthopedic conditions, announced the launch of its latest offering, nanOss strata-synthetic bone graft, which is developed with hydroxycarbonapatite (HCA), a material characterized by higher solubility as compared to traditional hydroxyapatite. Such developments are likely to support industry growth in the forecast period.

The increasing use of bone grafts in dentistry is adding to the growth potential of the dental bone grafts and substitutes market. Furthermore, dental implant surgery has become very popular with advanced surgical techniques, such as bone grafts and bone regeneration. Moreover, dental implants are the most preferred solution for individuals experiencing tooth-based conditions. both practitioner skills and the emerging technology supporting dental implants continue to evolve.

However, shifting trends and inclination among dental practitioners towards offering convenience without compromising patient safety, multiple manufacturers in this industry have been adding innovative products to their product lines. For instance, in February 2025, one of the key participants in regenerative medicine and the life sciences industry, LifeNet Health, introduced OraGen, a viable dental bone allograft, equipped with cryopreserved corticocancellous bone comprising endogenous lineage. Such product launches and accessibility to solutions that improve the effectiveness of dental procedures are projected to fuel the market growth.

Some of the key technological advancements expected to boost market growth are:

• Development of patient-specific, customized scaffolds using 3D printing.

• Use of bioactive peptides, which enable natural healing while significantly reducing the risk of unwanted ectopic bone growth.

• Digital integration, imaging-guided surgeries, and the use of AI-powered tools ensure precise procedures while ensuring lower recovery time.

Furthermore, a supportive regulatory framework is anticipated to support the bone grafts and substitutes market potential. For instance, the Breakthrough Device Program by the U.S. FDA focuses on helping the acceleration of development and review of innovative devices that offer enhanced treatments for lethal or irreversibly debilitating medical conditions. In October 2024, Amphix Bio, a company engaged in the development of regenerative medicine, announced that the FDA granted Breakthrough Device designation to its off-the-shelf bone graft substitute, AMFX 100. Such advancements and supportive government programs are fueling the market growth.

Rising adoption of minimally invasive procedures is further escalating the demand for bone grafts and substitutes. Surgeons are choosing minimally invasive procedures instead of open or traditional approaches owing to various benefits associated with MIS, such as quick procedure, less recovery time, shorter hospital stays, and fewer incisions. According to data from the American Academy of Orthopedic Surgeons (AAOS), the number of minimally invasive orthopedic procedures performed in the U.S. has been increasing steadily over the years. Some of the commonly performed minimally invasive orthopedic procedures in the U.S. are arthroscopy, spine surgeries, fracture repair, and joint replacement procedures. Thus, a rising number of MIS is anticipated to drive the global bone grafts and substitutes market at a significant pace.

The increasing incidence of bone disorders due to road accidents and sports injuries is driving the bone grafts and substitutes industry. Bone grafts can be used for the following purposes:

• To repair a broken bone

• To repair previously injured bone that has not healed.

• Spinal fusion (in case of an unstable spine)

• Bone regeneration

• To heal the bone around surgical implantation (joint & knee replacement)

Market Concentration & Characteristics

The global bone grafts and substitutes market demonstrates a high degree of innovation, driven by advancements in compositions and a shift from the use of materials that only act as fillers or scaffolds to the adoption of bioactive materials. For instance, in August 2025, University of Florida Startup, NovaBone, one of the key players in revolutionary synthetic bone graft technologies, unveiled its innovative NovaBone Bioactive Precontoured Wedges.  

The level of M&A activities is evidently higher in this market, owing to growth strategies embraced by major market players in the musculoskeletal healthcare and orthopedic reconstructive products manufacturing industry. For instance, in January 2025, Zimmer Biomet Holdings, Inc. announced it had entered into a definitive agreement to acquire all outstanding shares of common stock of Paragon 28.

Regulatory frameworks from the U.S. FDA, European Medicines Agency (EMA), and other regional authorities strongly influence the bone grafts and substitutes market. Stringent regulatory approval requirements to ensure safety and efficacy often result in lengthening of development timelines and increasing costs.

Manufacturers are actively targeting untapped regional markets, partnering with local distributors, and tailoring solutions to meet regional healthcare industry. Expansion efforts focus on increasing accessibility, strengthening presence in emerging economies.

Product Insights

The allograft segment dominated the market with the largest revenue share of 59.67% in 2025, owing to factors such as biological advantages associated with the allografts and surgical efficiency. In addition, aspects such as the presence of natural growth facilitators, such as Bone Morphogenetic Proteins (BMPs), and the ability of allografts to provide necessary mineral density, porosity, and collagen alignment also contribute to the allograft market segment growth.In January 2026, Cerapedics announced FDA approval for expanded use of PearlMatrix P-15 Peptide Enhanced Bone Graft, making it the only Class III drug-device spinal bone graft approved for all major lumbar interbody fusion approaches, including use with allograft and multiple cage materials.

The synthetic segment is projected to grow at the fastest CAGR during the forecast period. Some of the noteworthy benefits offered by synthetic products, such as eliminating the risk of immunogenicity & disease transmission, unlimited supply availability, and cost-effectiveness, are primarily fueling the growth of this segment. In recent years, continuous R&D efforts have been made to address gaps in the desired biological performance of synthetics. This has led to new product developments and innovation by prominent industry players. For instance, in February 2026, Medtronic announced that it had received Premarket Approval (PMA) for its INFUSE Bone Graft, specifically in Transforaminal Lumbar Interbody Fusion (TLIF) procedures at one or two levels from L2–S1, from the U.S. FDA. Emergence of such products equipped with effective, laboratory-manufactured proteins, which are easily available as compared to bone harvested from a donor, is expected to support the growth potential of this market segment from 2026 to 2033.

Application Insights

The spinal fusion segment accounted for the largest revenue share of 60.84% in 2025.A rising number of cases associated with medical conditions such as chronic back pain, scoliosis, and herniated discs has resulted in a growing number of spinal fusion surgeries. A research article titled "Global prevalence and associated risk factors of scoliosis in children and adolescents: a systematic review and meta-analysis", published in BMC Public Health journal, volume 25, in October 2025, stated the overall impact of scoliosis in young populations and some of the key contributors to it. The study featured analysis of nearly 239 studies involving 46,565,512 participants, concluded that the global prevalence of scoliosis was growing, and approximately 1.65% children and adolescents were affected by this life-threatening condition.

In addition, the emergence of modern technologies developed to address complexities in spinal fusion procedures associated with cervical, sacroiliac, and thoracolumbar spine support market growth. For instance, in December 2025, Carlsmed, Inc. announced the launch of its aprevo platform, developed for cervical fusion surgeries, which assists surgeons by combining AI-driven preoperative planning expertise with 3D-printed, patient-specific, customized implants. Such developments also contribute to the dominance of this segment.

The dental segment is projected to grow at the fastest CAGR during forecast period, owing to the increasing inclination among patients to opt for dental procedures instead of other forms of treatment and the growing prevalence of oral diseases. For instance, according to an article published by the WHO in March 2025, nearly 3.70 billion individuals are affected by oral diseases globally, and untreated dental caries (tooth decay) are the most common conditions. Considering the nature and accessibility of dental procedures in numerous countries, a large number of markets are still untapped for this segment and present lucrative growth opportunities.

Regional Insights

North America Bone Grafts And Substitutes Market Trends

North America dominated the bone grafts and substitutes market with a revenue share of 41.96% in 2025.The presence of multiple bone grafts and substitute manufacturers in the country, accessibility to sophisticated healthcare infrastructure required for complicated surgeries, and availability of innovative products contribute to the dominance of this regional market. The R&D capabilities of healthcare technology companies operating in the region, ongoing research activities, and new product developments also play a pivotal role in the growth experienced by this industry in North America.

U.S. Bone Grafts And Substitutes Market Trends

The U.S. held the largest market share of North America bone grafts and substitutes market in 2025, owing to the growing innovations and product launches featuring first-of-a-kind compositions, novel materials, and ingredients characterized with revolutionary capabilities are primarily influencing the growth of this market. For instance, in June 2025, Cerapedics Inc. announced that it had received FDA premarket approval for its newly developed P-15 peptide-based offering, PearlMatrix, as a Class III drug-device combination product for utilization in single-level transforaminal lumbar interbody fusion (TLIF) surgery of adult patients affected with degenerative disc disease (DDD). Fueled by innovation and supported by a positive regulatory scenario, the U.S. bone grafts and substitutes market is expected to experience significant growth.

Europe Bone Grafts And Substitutes Market Trends

The bone grafts and substitutes market in Europe is anticipated to witness noteworthy growth owing to the increasing number of cases associated with spinal injuries, musculoskeletal disorders, and fragility fractures in the region. In February 2024, according to the International Osteoporosis Foundation, nearly 831,000 fragility fractures are recorded annually in Germany, equivalent to almost 95 broken bones every hour. This develops a growing demand for surgical solutions that facilitate timely recovery and improved patient outcomes.

The bone grafts and substitutes market in Germany dominated the Europe’s regional industry. This is attributed to the increasing number of surgeries in the country. For instance, according to the International Osteoporosis Foundation, in 2024, nearly 5.6 million people were affected by osteoporosis in Germany. Such statistics indicate factors that may develop a strong demand for bone grafts and substitutes in the coming years.

Asia Pacific Bone Grafts And Substitutes Market Trends

The Asia Pacific bone grafts and substitutesindustry is projected to experience the fastest growth rate over the forecast period. The increasing focus of multiple global companies on Southeast Asia and other Asian markets primarily drives this growth trend. In 2024, according to Police Departments of States and Union Territories 480,583 road accidents were recorded in India. Increasing adoption of innovative surgical solutions and the rising number of surgeries, especially associated with the spine, are expected to generate greater demand for this market.

China dominated Asia Pacific bone grafts and substitutes market with largest revenue share in 2025. Multiple factors contribute to this scenario, including the presence of various manufacturers in the country who have modern technologies that facilitate mass production and easy accessibility to advanced materials used in the production of novel products. Growing demand within the country, fueled by factors such as an aging population, a rising number of new cases associated with musculoskeletal disorders, and the growing availability of products offered by global companies, also contributes to growth.

Latin America Bone Grafts And Substitutes Market Trends

Bone grafts and substitutes industry in The Latin America is anticipated to witness considerable growth over the forecast period, driven by the growing availability of products from key manufacturers in North America. The presence of a large population aged 65 and above also presents a significant opportunity for this market in the region. In October 2024, according to PAHO/OPS, Brazil had 23,424,114 people aged 65 and over, representing 10.9% of the total population. This contributed to an aging index of 55.2, with 55 older adults for every 100 children under 15. Such demographic factors and the growing number of surgeries are expected to provide significant growth potential to this market.

Brazil bone grafts and substitutes market held the largest revenue share of this market and is anticipated to witness rapid growth over the forecast period. Nearly 400,000 fragility fractures are recorded in Brazil annually. In addition, Brazil is one of the preferred destinations for orthopedic treatments in the region. Such developments are expected to support the market growth.

Middle East And Africa Bone Grafts And Substitutes Market Trends

Bone grafts and substitutesmarket in MEA is anticipated to witness considerable growth over the forecast period, fueled by improving healthcare infrastructure, growing availability of products manufactured by key manufacturers from Europe and North America, and rising inclination towards surgeries over treatments that range up to multiple weeks.

Bone grafts and substitutesindustry in UAE is anticipated to grow at the fastest CAGR during the forecast period, owing to strong healthcare expenditure in the country and the availability of modern healthcare infrastructure backed by advanced technologies and systems. It is also one of the preferred countries for medical tourists who visit international healthcare facilities that provide premium quality services and procedures performed by expert surgeons.

Recent Developments

• In December 2025, RevBio received approval from the U.S. FDA to commence with a pilot clinical trial that can assess the safety and efficacy of TETRANITE. ReviBio’s regenerative bone glue is designed to facilitate dental ridge augmentation procedures while eliminating the necessity of ancillary containment devices.

• In December 2025, Axogen Corporation, engaged in the development and marketing of innovation-driven surgical technologies, announced receiving approval of Biologics License Application (“BLA”) by the U.S. FDA, for AVANCE, an acellular nerve allograft.

• In November 2025, OST Laboratories announced the launch of virus-inactivated cancellous bone allografts, designed to simplify the obturating of drill tunnels and reduce inflammation and bleeding.

• In January 2025, NovaBone joined forces with BEGO for a strategic distribution partnership, specifically to address European market demand. This allows NovaBone to leverage BEGO’s broad distribution network in the local market.

Bone Grafts And Substitutes Market Report Scope

Global Bone Grafts And Substitutes Market Report Segmentation

This report forecasts revenue growth at global, regional & country levels and provides an analysis of the industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global bone grafts and substitutes market report based on material type, application, and region:

• Material Type Outlook (Revenue in USD Million; Unit Volume in Thousand Units, 2021 - 2033)

  • Allograft

    • Demineralised Bone Matrix

    • Others

  • Synthetic

    • Ceramics

      • HAP

      • ß-TCP

      • α-TCP

      • bi-phasic calcium phosphates (BCP)

      • Others (calcium sulphates, tricalcium phosphate)

    • Composites

    • Polymers

    • Bone Morphogenic Proteins (BMP)

• Application Outlook (Revenue USD Million, 2021 - 2033)

  • Craniomaxilofacial

  • Dental

  • Foot and Ankle

  • Joint Reconstruction

  • Long Bone

  • Spinal Fusion

• Regional Outlook (Revenue in USD Million; Unit Volume in Thousand Units, 2021 - 2033)

  • North America

    • U.S.

    • Canada

    • Mexico

  • Europe

    • UK

    • Germany

    • France

    • Italy

    • Spain

    • Denmark

    • Sweden

    • Norway

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Thailand

  • Latin America

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE

    • Kuwait